Bracket buys Clintara for enrollment tech; Google eyes clinical trials with smartwatch;

> Bracket, a provider of clinical trial technology, acquired Clintara for its study enrollment software. More

> Evotec and partner Roche ($RHHBY) endured a Phase II failure for their in-development Alzheimer's therapy. News

> Google ($GOOG) is designing a smartwatch designed for use in clinical trials. Item

Suggested Articles

Data firm Syapse has begun working with the FDA to help bring real-world evidence to bear on the agency’s decisions to approve cancer drugs.

The People-Centered Research Foundation tapped Datavant to de-identify real-world data across its national clinical research network.

Boehringer Ingelheim and MD Anderson Cancer Center have joined forces to create a “virtual” R&D hub so the pair can work on cancer drugs.